These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31676284)

  • 1. VHH characterization.Recombinant VHHs: Production, characterization and affinity.
    Chabrol E; Stojko J; Nicolas A; Botzanowski T; Fould B; Antoine M; Cianférani S; Ferry G; Boutin JA
    Anal Biochem; 2020 Jan; 589():113491. PubMed ID: 31676284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of camelid single-domain antibodies against HER2.
    Hussack G; Raphael S; Lowden MJ; Henry KA
    BMC Res Notes; 2018 Dec; 11(1):866. PubMed ID: 30518413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH.
    Hartmann L; Botzanowski T; Galibert M; Jullian M; Chabrol E; Zeder-Lutz G; Kugler V; Stojko J; Strub JM; Ferry G; Frankiewicz L; Puget K; Wagner R; Cianférani S; Boutin JA
    Protein Sci; 2019 Oct; 28(10):1865-1879. PubMed ID: 31423659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
    Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
    Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
    J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.
    Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Mahboudi F; Ahmadvand D; Sharifzadeh Z; Parhamifar L; Moghimi SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):378-86. PubMed ID: 24076235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept.
    Khoshtinat Nikkhoi S; Rahbarizadeh F; Ahmadvand D; Moghimi SM
    Eur J Pharm Sci; 2018 Sep; 122():42-50. PubMed ID: 29933078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing.
    Miyazaki N; Kiyose N; Akazawa Y; Takashima M; Hagihara Y; Inoue N; Matsuda T; Ogawa R; Inoue S; Ito Y
    J Biochem; 2015 Sep; 158(3):205-15. PubMed ID: 25888581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of recombinant variable domain of heavy chain anti-idiotypic antibodies specific to aflatoxin B1.
    Wang D; Xu Y; Tu Z; Fu JH; Xiong YH; Feng F; Tao Y; Lei D
    Biomed Environ Sci; 2014 Feb; 27(2):118-21. PubMed ID: 24625402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of single-domain antibodies with an engineered disulfide bond.
    Hussack G; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():417-29. PubMed ID: 22886266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?
    Smolarek D; Bertrand O; Czerwinski M
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():348-58. PubMed ID: 22706121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
    Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
    Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
    Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
    Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
    Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirror-Image Single-Domain Antibody for a Novel Nonimmunogenic Drug Scaffold.
    Aoki K; Manabe A; Kimura H; Katoh Y; Inuki S; Ohno H; Nonaka M; Oishi S
    Bioconjug Chem; 2023 Nov; 34(11):2055-2065. PubMed ID: 37883660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity transfer to a human protein by CDR3 grafting of camelid VHH.
    Inoue H; Iihara A; Takahashi H; Shimada I; Ishida I; Maeda Y
    Protein Sci; 2011 Dec; 20(12):1971-81. PubMed ID: 21910150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling.
    Rossotti MA; Henry KA; van Faassen H; Tanha J; Callaghan D; Hussack G; Arbabi-Ghahroudi M; MacKenzie CR
    Biochem J; 2019 Jan; 476(1):39-50. PubMed ID: 30455372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
    Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
    Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery.
    Kijanka M; Warnders FJ; El Khattabi M; Lub-de Hooge M; van Dam GM; Ntziachristos V; de Vries L; Oliveira S; van Bergen En Henegouwen PM
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1718-29. PubMed ID: 23778558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.